University of California, San Francisco (UCSF) - Innovation, Technology & Alliances — San Francisco, California

University of California, San Francisco (UCSF) - Innovation, Technology & Alliances is a clinical research site located in San Francisco, California, United States 94117.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

University of California, San Francisco (UCSF) - Innovation, Technology & Alliances has participated in 1 clinical trials.

Therapeutic areas: Relapsed, Diffuse Large B-cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma.

Sponsors: Nordic Nanovector.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California, San Francisco (UCSF) - Innovation, Technology & Alliances?

University of California, San Francisco (UCSF) - Innovation, Technology & Alliances has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California, San Francisco (UCSF) - Innovation, Technology & Alliances conducted?

University of California, San Francisco (UCSF) - Innovation, Technology & Alliances has 1 clinical trials on record. Their work covers Relapsed, Diffuse Large B-cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma.

Is University of California, San Francisco (UCSF) - Innovation, Technology & Alliances accredited by Crixeo Health?

University of California, San Francisco (UCSF) - Innovation, Technology & Alliances has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California, San Francisco (UCSF) - Innovation, Technology & Alliances?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.